Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
ItalyComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
ItalyPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
ItalyA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
ItalyLong-Term Study of Imeroprubart in Adults With Graves' Disease
ItalyVolrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
ItalyBMN 333 Versus Vosoritide in Children With Achondroplasia
ItalyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
ItalyFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
ItalyLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
ItalyBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
ItalyAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
